Colorectal SRCC predominantly affects young patients and presents at an advanced stage with aggressive clinicopathological features and poor oncological outcomes, and early diagnosis, multidisciplinary management, and prospective multicentre studies incorporating comprehensive molecular profiling are required to improv...
Arul Kumar A, Vasireddy Sadasivudu, H. Karun et al.· Cureus· 0 citations
Findings underscore the importance of tumor biology over environmental factors in survival and highlight the need for early detection and novel therapeutic strategies in MM.
P. Majumdar, Sonal Tripathi, Paramita Paul et al.· SN Comprehensive Clinical Me...· 0 citations
KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.
A. Kapoor, Bipinesh Sansar, Anuj Gupta et al.· Medical Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.